Revenue

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenue

4. Revenue

Disaggregation of revenue

The Company disaggregates revenue from customers with contracts into four product categories: Minerva ES, Genesys HTA, Symphion and Other (in percentages):

	Years Ended December 31,
		2022	2021
Minerva ES		45.9%	46.8%
Genesys HTA		29.3%	31.6%
Symphion		24.1%	20.6%
Other		0.7%	1.0%
		100%	100%

For the years ended December 31, 2022 and 2021, 99.9% and 99.0% of the Company’s revenue is subject to point-in-time recognition for single-use (disposable) products and capital equipment sales. Sale of extended warranties on capital equipment represents less than 1.0% of the Company’s revenue. In addition, for the years ended December 31, 2022 and 2021, 98.1% of the Company’s total revenue is derived from the sale of single-use (disposable) products; therefore, the Company did not include disaggregated revenue data to present the amounts attributed to capital equipment, associated warranties, and miscellaneous revenue separately.

Contract balances

The Company’s contract balances consist of the following (in thousands):

	December 31,		December 31,
	2022		2021
Accounts receivable, net	$	7,244	$	7,292
Contract liability—current (see Note 6)	$	339	$	206

Contract liabilities as of December 31, 2020 were $0.2 million. During the years ended December 31, 2022 and 2021, the Company recognized revenues of $0.1 million and $0.2 million, respectively, which were included in the contract liabilities at the beginning of the year.